Co-targeting ferroptosis and immune evasion through small molecules in breast cancer
Journal of Translational Internal Medicine · 22.12.2025 · 13 (6) · 516-536
DOI: 10.1515/jtim-2025-0093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 22.12.2025. Verfasst von Jianbo Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Pharmacy, West China School of Medicine, Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Ce…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer accounts for the highest proportion of cancer cases among women worldwide. Despite remarkable advances in cancer diagnosis and treatment, novel precision therapy strategies for various subtypes of breast cancer are urgently needed. Ferroptosis, which is different from programmed cell death, such as apoptosis, necrosis, and pyroptosis, is considered an alternative method for cancer therapy. A comprehensive understanding of ferroptosis in breast cancer is lacking, including, but not limited to, ferroptotic inducers (small molecule drugs and natural products) and the interaction between ferroptosis and immunotherapy. Induction of ferroptosis is recognized as a novel and promising strategy for cancer pharmacotherapy, and a comprehensive understanding of the role of ferroptosis in breast cancer could help provide alternative treatment strategies for breast cancer. Furthermore, we highlight the signaling crosstalk bridging ferroptosis with the immune microenvironment and the feasibility of targeting their potential regulators ( e.g ., STAT3, AR, EZH2, and PRMT5) using small molecules to simultaneously achieve the induction of ferroptosis and inhibition of immune escape.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China School of Pharmacy, West China School of Medicine, Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichu…
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong Province, China.
- Department of Urology, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan Province, China.
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, Sichuan Un…
ORCID-Profile: Zhaokai Zhou, Fu Peng
Zitieren
APA
Zhou, J., Yang, W., Tang, H., Zou, Y., Zhou, Z., Peng, C., & Peng, F. (2025). Co-targeting ferroptosis and immune evasion through small molecules in breast cancer. Journal of Translational Internal Medicine, 13(6), 516-536. https://doi.org/10.1515/jtim-2025-0093
Vancouver
Zhou J, Yang W, Tang H, Zou Y, Zhou Z, Peng C, et al. Co-targeting ferroptosis and immune evasion through small molecules in breast cancer. Journal of Translational Internal Medicine. 2025;13(6):516-536. doi:10.1515/jtim-2025-0093
BibTeX
@article{Zhou2025,
author = {Zhou, Jianbo and Yang, Wangji and Tang, Hailin and Zou, Yutian and Zhou, Zhaokai and Peng, Cheng and Peng, Fu},
title = {Co-targeting ferroptosis and immune evasion through small molecules in breast cancer},
journal = {Journal of Translational Internal Medicine},
year = {2025},
volume = {13},
number = {6},
pages = {516--536},
doi = {10.1515/jtim-2025-0093}
}
EUVIMED